221 related articles for article (PubMed ID: 34057410)
1. Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra.
Choi CH; Ma SH; Ma KK; Leung H; Mok VC
Epileptic Disord; 2021 Jun; 23(3):500-505. PubMed ID: 34057410
[TBL] [Abstract][Full Text] [Related]
2. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
3. Febrile infection-related epilepsy syndrome treated with anakinra.
Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
[TBL] [Abstract][Full Text] [Related]
4. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
Sheikh Z; Hirsch LJ
Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
[TBL] [Abstract][Full Text] [Related]
5. Rasmussen's syndrome treated with anakinra.
Arcan A; Kızılkılıç EK; Gündüz A; Unkun R; Vezzani A; Özkara Ç
J Neurol; 2024 Feb; 271(2):723-726. PubMed ID: 37922068
[TBL] [Abstract][Full Text] [Related]
6. [Acute encephalitis with refractory partial status epilepticus treated with early immunotherapies including plasma exchange: a case report].
Yamamoto D; Uchiyama T; Bunai T; Sato K; Shimizu T; Tanaka K; Ohashi T
Rinsho Shinkeigaku; 2014; 54(9):715-20. PubMed ID: 25283825
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy Emergencies: Status Epilepticus, Acute Repetitive Seizures, and Autoimmune Encephalitis.
VanHaerents S; Gerard EE
Continuum (Minneap Minn); 2019 Apr; 25(2):454-476. PubMed ID: 30921018
[TBL] [Abstract][Full Text] [Related]
8. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES).
Stredny CM; Case S; Sansevere AJ; Son M; Henderson L; Gorman MP
Child Neurol Open; 2020; 7():2329048X20979253. PubMed ID: 33403221
[TBL] [Abstract][Full Text] [Related]
10. New-onset refractory status epilepticus: Etiology, clinical features, and outcome.
Gaspard N; Foreman BP; Alvarez V; Cabrera Kang C; Probasco JC; Jongeling AC; Meyers E; Espinera A; Haas KF; Schmitt SE; Gerard EE; Gofton T; Kaplan PW; Lee JW; Legros B; Szaflarski JP; Westover BM; LaRoche SM; Hirsch LJ;
Neurology; 2015 Nov; 85(18):1604-13. PubMed ID: 26296517
[TBL] [Abstract][Full Text] [Related]
11. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
12. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier.
Hainsworth JB; Shishido A; Theeler BJ; Carroll CG; Fasano RE
Epileptic Disord; 2014 Dec; 16(4):486-93. PubMed ID: 25465280
[TBL] [Abstract][Full Text] [Related]
13. Seizures and memory impairment induced by patient-derived anti-N-methyl-D-aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin-1 receptor antagonist.
Taraschenko O; Fox HS; Zekeridou A; Pittock SJ; Eldridge E; Farukhuddin F; Al-Saleem F; Devi Kattala C; Dessain SK; Casale G; Willcockson G; Dingledine R
Epilepsia; 2021 Mar; 62(3):671-682. PubMed ID: 33596332
[TBL] [Abstract][Full Text] [Related]
14. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report.
Gagnon MM; Savard M; Mourabit Amari K
Seizure; 2016 Apr; 37():25-7. PubMed ID: 26921483
[TBL] [Abstract][Full Text] [Related]
15. Long-term and Strong Immunotherapy to Treat Anti-N-Methyl- D-Aspartate Receptor Encephalitis with Refractory Status Epilepticus.
Lee LH; Lu CJ
Acta Neurol Taiwan; 2016 Sep; 25(3):99-103. PubMed ID: 27854088
[TBL] [Abstract][Full Text] [Related]
16. Predictors of outcome in super refractory status epilepticus.
Jose J; Keni RR; Hassan H; Menon R; Sukumaran S; Cherian A; Radhakrishnan A
Epilepsy Behav; 2021 May; 118():107929. PubMed ID: 33775578
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane as bridge therapy for plasma exchange and Anakinra in febrile infection-related epilepsy syndrome.
L'Erario M; Roperto RM; Rosati A
Epilepsia Open; 2021 Dec; 6(4):788-792. PubMed ID: 34596364
[TBL] [Abstract][Full Text] [Related]
18. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto's encephalopathy: A rare cause of refractory status epilepticus.
Guo Z; He X; Zhang G; Zhang C; Tao A; Wang B; Wang X; Li L; He M
CNS Neurosci Ther; 2021 Mar; 27(3):372-375. PubMed ID: 33347693
[No Abstract] [Full Text] [Related]
20. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
